SCTX smart money
Scribe Therapeutics, INC. (SCTX): 4 insider buys, 3 top funds holding it, 1 ETF change in the public filings.
Insider buys, 12 months$71.3M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-07-29 | Gordon Carl L | Director | $15.0M | $15.0 |
| 2026-07-29 | Orbimed Advisors LLC | Director | $15.0M | $15.0 |
| 2026-07-29 | Ah Equity Partners Bio II, L.L.C. | TenPercentOwner | $5.0M | $15.0 |
| 2026-07-28 | Avoro Ventures LLC | Director,Other | $36.3M | $18.25 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 24 | Orbimed Advisors LLC | BUY | 0.46% | $25M |
| 71 | Baker Bros. Advisors LP | BUY | 0.06% | $13M |
| 80 | Avoro Capital Advisors LLC | BUY | 0.49% | $48M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| Ark Genomic Revolution ETF | BUY | +$7M | 2026-07-31 |